Train harder · Free ship $75+ · Gear up now
dihexa retracted paper controversy

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :

SKU: 72192070904

4.8
USD28.39 USD68.39

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 26 - Aug 31

Description

Bondanelli M, Ambrosio MR, Onofri A, Bergonzoni A, Lavezzi S, Zatelli MC, et al

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :

Neurological Health

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :

doi: 10.1007/s11239-010-0538-5

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :

You might experience symptoms like a headache, nausea, fatigue, or brief irritation at the injection site

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :

Precision Dosing: The use of nasal sprays allows for precise dosing, ensuring consistent delivery of peptides, vital for maintaining the integrity of research conditions and results

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :

Microbiol Spectr

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate How Bad Is This? :
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Semaglutide
Semaglutide

US$ 20.26

4.0 (18 reviews)

FWD Care
FWD Care

US$ 23.67

4.2 (27 reviews)

recommand products